Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
Expert Review of Clinical Immunology|February 7, 2018
Allergic rhinitis management: what's next?Farnaz Tabatabaian, Thomas B CasaleAllergy and Asthma Proceedings|February 26, 2015
Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT)Farnaz Tabatabaian, Thomas B CasaleDrugs|June 13, 2016
Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future DirectionsAdeeb Bulkhi, Farnaz Tabatabaian, Thomas B CasaleImmunology and Allergy Clinics of North America|April 4, 2017
Biologic and New Therapies in AsthmaFarnaz Tabatabaian, Dennis K Ledford, Thomas B CasaleSeminars in Respiratory and Critical Care Medicine|October 11, 2022
Current Biologics in Asthma TreatmentDonya Imanirad, Farnaz TabatabaianJournal of Asthma and Allergy|April 18, 2018
Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical historyFarnaz Tabatabaian, Dennis K LedfordThe Journal of Biological Chemistry|April 23, 2010
Mammalian target of rapamycin (mTOR) and S6 kinase down-regulate phospholipase D2 basal expression and functionFarnaz Tabatabaian, Kevin Dougherty, Mauricio Di Fulvio, et al.The Journal of Allergy and Clinical Immunology|September 30, 2022
Novel biologics for treatment of chronic spontaneous urticariaThomas B CasaleDrugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitisThomas B Casale, Postgraduate Medicine|August 12, 2009
The pathophysiology of small airway inflammation in asthmaThomas B CasalePageof 20